[This review was originally posted at the Nieman Journalism Lab Order Glucophage, on Sept. 9, 2011.]

TechCrunch, ethics, and new notions of journalism: The prominent tech news site TechCrunch tends to find itself in the middle of some controversy or another fairly regularly. Usually they're relatively inconsequential inside baseball, but this week's blowup is by far its biggest, and it spurred some enlightening discussion outside of the tech-news bubble, canada, mexico, india.

Here's the quick summary of what happened (the Guardian has a fuller version): Michael Arrington, TechCrunch's founder and editor, launched a venture capital fund to invest in tech companies — the same companies TechCrunch covers. AOL, which bought the site last year, responded by taking him off of TechCrunch and moving him to the business side in an arrangement that no one completely understood. Arrington fired back with an ultimatum: Give TechCrunch total editorial freedom, or sell it back to him, Order Glucophage. Effects of Glucophage, AOL has reportedly countered by booting Arrington entirely. Whatever happens, TechCrunch's MG Siegler said the site won't likely be the same.

There were conflicting views on the impact of Arrington's reported ouster, of course — Reuters' Felix Salmon said AOL is losing its top journalist, while Fortune's Chadwick Matlin said the fall of TechCrunch would be good for the tech industry. But the central issue here was the ethics of Arrington's arrangement — investing in the same companies his site covers, something he's been doing openly for years, real brand Glucophage online.

The critique was articulated most strongly by the New York Times' David Carr Order Glucophage, , who documented several instances of TechCrunch writing favorable pieces on companies in which Arrington had invested, calling the arrangement "almost comically over the line." All Things Digital's Kara Swisher delivered an angrier version — "A giant, greedy, Silicon Valley pig pile" — and many others were also critical, including the Atlantic's Alexis Madrigal, Rem Rieder of the American Journalism Review, and VentureBeat's Dylan Tweney.

TechCrunch had its defenders, too, including Gawker's Ryan Tate, who argued for the hypocrisy of AOL's Arianna Huffington's sudden concern about ethics. The most thorough defenses, though, Glucophage coupon, came from TechCrunch's writers themselves: First, Paul Carr asserted that the new company would have nothing to do with TechCrunch. Then, both Carr and MG Siegler responded to David Carr's column by arguing that their site doesn't have the editorial workflow that its critics assume, and by criticizing the Times for its own ethical conflicts. "Ultimately there is only one thing that matters: information. People don’t care how they get it, just that they get it. If they don’t think they can trust it from one source, they’ll find another way to get it," Siegler wrote, Order Glucophage.

Some observers, buy cheap Glucophage no rx, like New York mag's Chris Rovzar, called that defense naive. In a terrific post here at the Lab, j-prof C.W. Anderson looked a bit deeper into the ways TechCrunch's philosophy challenges traditional journalism's norms, particularly the site's commitment to transparency as its primary ethical safeguard and its idea of the supremacy of information. About Glucophage, There was also the question of whether Arrington should have to abide by journalistic standards in the first place. Arrington asserted Order Glucophage, that he's not a journalist, and tech pioneer Dave Winer argued that "journalism itself is becoming obsolete." GigaOM's Mathew Ingram countered that journalism is still alive, just evolving and expanding, and j-prof Jeff Jarvis said journalism defies definition, and that's just fine.

—

A bigger challenge for Digital First: John Paton has grabbed a lot of attention with his rejuvenation of the formerly bankrupt newspaper chain the Journal Register Co., and this week, his project expanded to include a much larger (also formerly bankrupt) company, MediaNews Group, which owns papers such as the Denver Post, St. Paul Pioneer Press, Glucophage gel, ointment, cream, pill, spray, continuous-release, extended-release, and Detroit News. Though the two companies will remain formally separate, Paton will manage both companies under the auspices of the newly created Digital First Media.

Paton briefly reiterated his digitally centered philosophy in a blog post on the move, and GigaOM's Mathew Ingram called him the "patron saint" of the digitally focused, open approach to newspapers, Buy Glucophage no prescription, as opposed to the more print-protectionist, paywall-oriented one. Reuters' Felix Salmon said Paton's model of leveraging local sales staff and trusted editorial content for digital revenue makes much more sense than the hyperlocal-en-masse Patch model, Order Glucophage.

There's another important aspect to this deal, though: the Journal Register Co. was bought this summer by Alden Global Capital, a hedge fund that also owns a significant stake in MediaNews and several other newspaper companies. The Lab's Joshua Benton provided some background on that situation, and Ken Doctor predicted that the move "may mark just the beginning of a local newspaper roll-up, Glucophage cost, resulting in the United States’ first truly national local news(paper) company," noting that Paton's Digital First initiative is also accompanied by major cost-cutting. At the Knight Digital Media Center, Amy Gahran expressed concern that Paton's plans could run aground on an entrenched traditional culture at MediaNews and the impatience of hedge-fund investors. Order Glucophage, MediaNews also has newly installed paywalls at 23 papers, and Paton told paidContent he isn't sure yet what will happen to them. But one change has already been made: MediaNews' contract with copyright litigant Righthaven has been ended.

—

WikiLeaks under fire: We talked last week about the inadvertent release of the rest of WikiLeaks' archive of 251, Glucophage pharmacy, 000 diplomatic cables and the fallout that ensued. As it happened, WikiLeaks decided late last week to go ahead and publish all of the unredacted cables themselves, given that they had already been leaked online.

The decision led to more criticism — not just from the traditional media, but from others on the web: the Personal Democracy Forum's Micah Sifry, author of a book on WikiLeaks, chastised the organization for the dump, online buy Glucophage without a prescription, saying it's thrown away the moral high ground. Consultant Tom Watson said WikiLeaks' move has damaged their efforts at transparency and an empowered society, and James Ball, a former WikiLeaks volunteer, made the same point more powerfully by painting a picture of an internal culture at odds with the group's stated ideals of accountability and openness. "WikiLeaks has done the cause of internet freedom – and of whistleblowers – more harm than US government crackdowns ever could," he said, Order Glucophage.

Tech blogger Dave Winer, however, After Glucophage, was more troubled by the traditional media's eagerness to blame and ostracize Assange for the incident. It's not about one person, he said, it's about the technology that makes WikiLeaks possible: "They have a method that they have religious feelings about, ones that some of us don't share, and that method is broken by the Wikileaks model." Mediaite's Frances Martel, meanwhile, wondered why no one seemed to care about the documents themselves, herbal Glucophage.

—

Yahoo fires its CEO: After a tumultuous two-and-a-half-year tenure, Yahoo CEO Carol Bartz was fired this week. The next step for the troubled Internet giant could be to engineer a sale, as CNNMoney's Paul La Monica urged it to do. Order Glucophage, Plenty of names were tossed around as potential buyers, most recently Yahoo co-founder Jerry Yang.

The Wall Street Journal detailed what's gone wrong at Yahoo, and Om Malik of GigaOM was one of many who pinned many of the company's failings on its board. Glucophage reviews, Malik called for Yahoo to rid itself of everything that connects it to the Internet's past, and Business Insider's Pascal-Emmanuel Gobry advised Yahoo to "own the fact that it's a media and content company," encouraging a strategy that looks quite similar to AOL's. PaidContent's David Kaplan noted that Yahoo has a lot of ground to make up in display advertising, and Mark Walsh of MediaPost wondered if we'll see more of an emphasis on mobile media from Yahoo now.

—

Reading roundup: Just a couple more items for this week:

— One piece of news to note: Google has killed FastFlip, the magazine-like news presentation tool it launched in 2009.

— As we continue to move closer to bona fide campaign season, Glucophage maximum dosage, the Columbia Journalism Review's Greg Marx offered a smart response to Jay Rosen's critique of political journalism last week, defending the usefulness of certain kinds of the much-maligned "horse-race journalism."

— On the practical side, Florida j-prof Mindy McAdams put together a handy list of 10 tips to compelling visual storytelling. It's a great resource for professionals, j-profs, and students.

Similar posts: Lipitor Cost. Cephalexin No Rx. Buy Retin A No Prescription. Armour results. Synthroid price, coupon. Armour price, coupon.
Trackbacks from: Order Glucophage. Order Glucophage. Order Glucophage. Order Glucophage online overnight delivery no prescription. Buy Glucophage online no prescription. Glucophage price, coupon.

[This review was originally posted at the Nieman Journalism Lab Purchase Glucophage, on July 18, 2011.]

News Corp.'s scandal keeps growing: Rupert Murdoch might have hoped News Corp.'s phone hacking scandal would die down when he closed the British tabloid News of the World last week, but it only served to fuel the issue's explosion. This past week, the scandal's collateral damage spread to News Corp.'s proposed takeover of the British broadcaster BSkyB: Faced with increasing pressure from the British government and the revelation that News Corp. journalists tried to get private records of former Prime Minister Gordon Brown, News Corp. dropped the BSkyB bid, which had been a huge part of the company's U.K. strategy. Buy no prescription Glucophage online, Plenty of other problems are cropping up for News Corp., too. The top lawyer for its U.K, Purchase Glucophage. newspaper branch, News International, quit. The company's stock lost $7 billion in four business days at one point. A pre-existing U.S. shareholders' suit expanded to cover the hacking scandal, is Glucophage addictive. The Murdochs have to testify before British Parliament Purchase Glucophage, this week about the scandal, and the FBI started investigating U.S.-related aspects of the issue. That's all in addition to the ongoing problems News Corp. faces, as detailed by Poynter's Rick Edmonds.

The scandal has led quite a few writers to criticize the culture that Murdoch has created at News Corp. Capital New York's Tom McGeveran and Reuters' John Lloyd railed on Murdoch and News Corp.'s character, Carl Bernstein called this Murdoch's Watergate, Canada, mexico, india, and the Observer's editorial board called for systemic reforms in Britain so Murdoch's influence can never be so strong. Members of the Bancroft family said they wouldn't have sold the Wall Street Journal to Murdoch in 2007 if they'd have known the hacking was going on, Purchase Glucophage.

On the other hand, the New York Times pointed out that sleazy British tabloid tactics are hardly limited to Murdoch, and media critic Howard Kurtz noted that they're very much alive in the U.S. mainstream press, too. New York Times columnist Roger Cohen defended Murdoch, saying he's been good for journalism on the whole, purchase Glucophage online, and Gawker's John Cook defended those tabloid reporting tactics. Meanwhile, j-prof Jeff Jarvis and the Telegraph's Toby Harnden urged the British government not to respond by enacting more regulation. Purchase Glucophage, News Corp.'s retreat might not stop with News of the World and BSkyB. Murdoch biographer Michael Wolff and others have reported that the company's execs are debating whether to get out of Britain's newspaper business entirely, and several observers chimed in to say that might actually make a good deal of business sense. Media analyst Ken Doctor said News International is losing steam, After Glucophage, and the Financial Times' John Gapper said newspapers are becoming far more trouble than they're worth to Murdoch.

Not only that, but the New Yorker's John Cassidy said dropping his U.K. newspapers could let Murdoch revive his BSkyB bid, and Jeff Jarvis speculated that when Murdoch chooses between the power that the papers give him and the money saved by getting rid of them, he'll choose the money. In an interview with the Wall Street Journal, Murdoch called the rumors of a newspaper sell-off "rubbish."

But just because News of the World and News International may be dead and dying, that doesn't mean newspapers as a whole are, argued David Carr of the New York Times, Purchase Glucophage. As he noted, it was the Guardian's dogged reporting that finally broke this story open. Murdoch "prefers his crusades to be built on chronic ridicule and bombast, Glucophage used for. But as The Guardian has shown, the steady accretion of fact — an exercise Mr. Murdoch has historically regarded as bland and elitist — can have a profound effect," Carr wrote. The Atlantic also had praise for the Guardian, and Poynter's Mallary Jean Tenore interviewed one of its editors about the lonely journey of covering the phone hacking story.

—

HuffPo aggregation under the microscope Purchase Glucophage, : A lively discussion about the rights and wrongs of aggregation developed last week out of a column by Ad Age media critic Simon Dumenco, who complained that the Huffington Post had extensively summarized one of his posts, buried the link to the original, and — contrary to Arianna Huffington's argument that her site benefits those they aggregate by sending them readers — gave him just 57 page views. Buy Glucophage without a prescription, The Huffington Post responded by apologizing and suspending the article's writer. HuffPo business editor Peter Goodman told Adweek the piece was a fully formed article when it should have been a simple introduction and a link, but Dumenco responded to the apology by arguing that the writer did nothing out of the ordinary — this is just how HuffPo tells its writers to do it.

Dumenco's point was echoed by several others: The Awl's Choire Sicha said the suspended writer was doing what she was taught, Gawker's Ryan Tate, drawing on a revealing quote from a former HuffPo writer, made the same point: "This is pretty ridiculous, given HuffPo's systematic, Glucophage dosage, officially-sanctioned approach to rewriting too much of people's news articles." British journalist Kevin Anderson called HuffPo's summary-heavy aggregation "a pretty cynical strategy," and paidContent's Staci Kramer said HuffPo needs to respect its sources, rather than treating a link as a favor.

Gabe Rivera, whose news site, Techmeme, Where can i order Glucophage without prescription, was compared to HuffPo favorably by Dumenco, looked for terms to distinguish what his site does from what HuffPo does. Poynter's Julie Moos said some measure of originality will always make for better journalism and a better business model than heavy aggregation, and ZDNet's Tom Foremski pined for the old blogging mentality whose goal was to add value, Purchase Glucophage. In a short podcast, author Steven Rosenbaum said this is a logical time to step back and evaluate exactly what constitutes ethical aggregation.

There were a few dissenters, though: GigaOM's Mathew Ingram and Slate's Jack Shafer both argued that the type of aggregation that HuffPo does has been around for ages in traditional media (especially in Britain, according to Forbes' Tim Worstall). In fact, Glucophage coupon, Shafer said, news orgs could learn a something valuable from the Huffington Post: "That a huge, previously ignored readership out there wants its news hot, quick, and tight."

—

Comparing Google+, Facebook, Cheap Glucophage, and Twitter: It's been just about three weeks since Google+ launched, and Google's new social network is growing like a weed, with estimates of as many as 10 million users so far. (Its number of active users may soon be approaching Twitter's figures.) Google+ news has dominated Twitter, and Google's also working on integrating it with Gmail. Purchase Glucophage, With Plus' incredible growth, tech observers have been going back and forth about what social network Google+ is disrupting most. PCWorld's Megan Geuss wondered whether Google+ and Facebook can coexist, and PC Magazine's John Dvorak posited that all the excitement about Google+ is more or less just pent-up frustration with Facebook. The New York Times' David Pogue and Technology Review's Paul Boutin both compared Google+ favorably to Facebook, largely because of its superior privacy controls (though GigaOM's Mathew Ingram pointed out that it may not be a privacy improvement for some people).

Meanwhile, Search Engine Land's Danny Sullivan said Google+ is more comparable to Twitter, Glucophage natural, then went ahead and made a thorough, smart comparison between the two. The Atlantic's Alexis Madrigal said Google+ might end up being more conversational than Twitter, which he called more of a call-and-response: Google+ "won't be as good at connecting people to information or each other quickly, but it might be better at longer form discussions and whatever we call the process by which people pull reasoned thoughts from their networks into public discourse." Hutch Carpenter said Google+ resembles both Facebook and Twitter, and Computer World's Mike Elgan wrote that it'll disrupt just about everything.

Still, Google+ has its limits: ReadWriteWeb's Marshall Kirkpatrick explained why he'd never move his personal blog there as some are doing, and Instapaper's Marco Arment and the Guardian's Dan Gillmor both urged readers to keep a space for their own online identity outside of spaces like Google+ or Facebook, Purchase Glucophage. For journalists feeling out Google+, Meranda Watling of 10, Glucophage from canada,000 Words put together a preliminary guide.

—

Reading roundup: Here's what else people were talking about this past week:

— The newspaper chain MediaNews made a distinctive play for the tablet news market last week, announcing the launch of TapIn, a location-based news app made specifically for tablets. It'll start in the Bay Area in partnership with the San Jose Mercury News. Ken Doctor, Jeff Sonderman, Glucophage overnight, and Mathew Ingram all wrote about what makes it worth watching.

— The Economist continued running pieces all week in its series on the future of the news industry. You can check out several writers'reasons for optimism or read the opening statements in an ongoing debate between NYU's Jay Rosen and author Nicholas Carr about whether the Internet has been good for journalism.

— Boston Globe developer Andy Boyle made his pitch for young journalists to go into web development, or as he put it, "learn to make the internets."

— Poynter's Jeff Sonderman put together two great social media how-to's for journalists: One on verifying information on social media, and the other on strategies for engagement on Facebook.

— Finally, NYU's Clay Shirky gave us another thoughtful essay on the unbundling of news and why the news ecosystem needs to be chaotic right now. In the end, though, here's what he believes news should be: "News has to be subsidized because society’s truth-tellers can’t be supported by what their work would fetch on the open market"; "news has to be cheap because cheap is where the opportunity is right now"; and "news has to be free, because it has to spread.".

Similar posts: Zoloft No Rx. Bactrim For Sale. Glucophage Price. Tramadol coupon. Glucophage for sale. Cephalexin reviews.
Trackbacks from: Purchase Glucophage. Purchase Glucophage. Purchase Glucophage. Glucophage dose. Buying Glucophage online over the counter. Rx free Glucophage.